Theralase Technologies Inc. (TSXV:TLT)
Canada
· Delayed Price · Currency is CAD 0.265
-0.005 (-1.85%)
Mar 9, 2026, 2:55 PM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 71.55 million as of March 9, 2026. Its market cap has increased by 6.95% in one year.
Market Cap
71.55M
Enterprise Value
71.79M
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.27
Market Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 71.55M, an increase of 759.20%. That is a compound annual growth rate of 7.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Perimeter Medical Imaging AI | 65.56M |
| Cannabix Technologies | 61.24M |
| Conavi Medical | 44.50M |
| Cheelcare | 36.37M |
| Ventripoint Diagnostics | 21.50M |
| Aurora Spine | 20.14M |
| Profound Medical | 256.96M |
| MedX Health | 18.04M |